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Gene regulatory networks: a primer in
biological processes and statistical modelling
Olivia Angelin-Bonnet, Patrick J. Biggs and Matthieu Vignes
Abstract Modelling gene regulatory networks not only requires a thorough under-
standing of the biological system depicted but also the ability to accurately represent
this system from a mathematical perspective. Throughout this chapter, we aim to fa-
miliarise the reader with the biological processes and molecular factors at play in
the process of gene expression regulation. We first describe the different interactions
controlling each step of the expression process, from transcription to mRNA and
protein decay. In the second section, we provide statistical tools to accurately repre-
sent this biological complexity in the form of mathematical models. Amongst other
considerations, we discuss the topological properties of biological networks, the ap-
plication of deterministic and stochastic frameworks and the quantitative modelling
of regulation. We particularly focus on the use of such models for the simulation of
expression data that can serve as a benchmark for the testing of network inference
algorithms.
Key words: Gene expression regulation, Regulatory network modelling, Systems
biology data simulation, Post-transcriptional regulation, Post-translational regula-
tion, Deterministic and stochastic models, Molecular regulatory interactions
1 Introduction
The different regulatory processes occurring within cells are often depicted as a
network of interacting entities. These entities can be mapped onto different layers
Olivia Angelin-Bonnet, Patrick J. Biggs & Matthieu Vignes
Institute of Fundamental Sciences
Patrick J. Biggs
School of Veterinary Science
Massey University, Private Bag 11 222, Palmerston North, 4442, New Zealand
e-mail: m.vignes@massey.ac.nz
1
ar
X
iv
:1
80
5.
01
09
8v
1 
 [q
-b
io.
QM
]  3
 M
ay
 20
18
2 O. Angelin-Bonnet, P.J. Biggs, M. Vignes
that represent the different biological molecules involved in expression regulation,
for example transcripts and proteins (Figure 1a). High-throughput studies provide us
with a measurement of the variable levels of a given layer. For example microarrays
or RNA sequencing technologies measure mRNA abundance, and are commonly
referred to as gene expression data. We refer the interested reader to [22] for such
modern data handling practices, to [7] for associated statistical designs and to [8]
for a data processing and primary analysis workflow.
From a biological perspective, entities from different layers are found to interact.
Indeed, in addition to the well-known control of transcription by proteins termed
transcription factors (TFs), other steps of the gene expression process are targeted
by regulatory molecules beyond proteins, e.g. small molecules such as metabolites
and noncoding RNAs. On top of this dynamic regulation, the information encoded
in the DNA itself exerts to some extent control over the expression profile of genes.
Here the term “gene” refers to a DNA sequence coding for a protein or other untrans-
lated RNA. However it is usually impossible to measure in the same experiment data
about all these molecular layers. We are therefore most of the time bound to making
the most of one given data type from which we seek to extract patterns giving in-
sight into the regulatory interactions at play. Thus gene regulatory networks (GRNs)
successfully gather the detected relationships between transcripts, even if these re-
lationships are mediated by other molecules such as proteins. GRNs represent these
interactions in a graph where nodes correspond to genes (and gene products) and
edges represent the regulatory relationships among them (Figure 1b).
The modelling of such regulatory systems is an important aspect of the reverse
engineering problem. Accounting for existing biological interactions can be key to a
more accurate analysis of experimental data, e.g. in the analysis of differential gene
expression [28]. In addition, such models can be used to simulate expression data
in order to assess the performances of a given network inference method, just like
data can be simulated to assess gene expression differential analysis method perfor-
mance [95]. Indeed, a detailed analysis of the strengths and weaknesses of a given
method can guide the choice of a practitioner to choose among the possible different
reverse engineering approaches and pave the way for needed method development.
A possibility is to use as a benchmark a previously studied experimental dataset, but
this approach is limited by our incomplete knowledge about true – if this truth is ever
an achievable objective – underlying pathways. On the contrary, the use of simulated
expression data from in silico networks renders possible the objective comparison
of the results of network inference to the true underlying interaction graph. More
precisely, synthetic data allows the assessment of the impact of sample size, noise
or topological properties of the underlying network on the methods performance.
To make valid conclusions, one expects synthetic data to have features as close as
possible to real data. Modelling such complex systems seems like a insurmountable
task. However, by carefully designing each constituting element of the model it is
possible to link the statistical representation of a regulatory system to the underlying
biological mechanisms in a meaningful way. This is the very topic of this work.
This chapter aims at bringing together the biological and statistical representation
of GRNs. In Section 2, we provide an overview of the different regulatory mecha-
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nisms that shape the gene expression profiles. We focus on the different regulatory
molecules that target each step of the expression process. In Section 3, we introduce
the reader to the basic concepts necessary to the construction of a GRN model, from
the topological properties shaping biological networks to the mathematical frame-
works used for the dynamic simulation of expression data and the representation of
regulation from a quantitative point of view. Together, this chapter provides a first
guide to GRN modelling anchored in the biological reality of gene expression regu-
lation.
Fig. 1 Biological versus statistical representation of a GRN. a) Biological regulatory systems are
complex: the different intermediary products of genes – transcripts and proteins – as well as
metabolites interact in a multi-layer network. Such networks are the best representation we can
give of a biological complex system. b) Statistical perspective: genes can be considered as nodes
in a directed graph, where the edges represent regulatory interactions. Each parent variable node
directly influences its children variables, therefore representing the regulation mechanism of a gene
product on the transcription of another gene.
2 Biological processes: from gene to protein
Proteins are the main actors in living organisms. They achieve a myriad of func-
tions. Yet their structure, their production mechanisms and their regulation to allow
the cell or organism to adequately adapt to the environment is dictated by the infor-
mation contained in the genetic material of the organism. The expression of a gene,
a “coding sequence” into an active protein is a complex process involving numerous
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biological molecules transformed via varied reactions and interactions. The infor-
mation encoded in the coding sequence of the DNA is transcribed into a messenger
RNA (mRNA), which is processed and translated into a protein, according to the
central dogma of biology. Once synthesized, a protein may require additional “post-
translational” modifications to acquire a functional form. In this section, we aim at
providing an overview of the different regulatory interactions targeting each of these
steps. This knowledge certainly helps data analysts designing more ad hoc models
to extract knowledge from modern high-throughput measurements. While it is out
of the scope of this chapter to provide a detailed and comprehensive description of
the specific biological mechanisms, we provide references to more biology-centred
reviews of the subject. An overview of the different molecular actors of this regula-
tion can be found in Figure 2.
2.1 Regulation of transcription
The regulation of transcription is believed to be a key determinant of gene expres-
sion profile [87, 130]. It mainly leverages the action of TFs which act as activators
or repressors for the transcription of target genes. Regulators act by binding to prox-
imal or distant sites on the promoter of the target genes. They impact transcription
by facilitating or restraining the recruitment of the transcriptional machinery to the
target gene via protein-protein interactions with its constituents. While TF binding
only involves proximal promoters in bacteria, additional remote regulatory elements
such as enhancers, insulators or locus control regions play an important role in the
regulation of eukaryotic genes [74, 130]. A given TF can affect the expression of
one or more target genes, and its impact on gene expression (i.e. activation, repres-
sion or modulation) can change in response to a specific environmental or molecular
stimulus. Typically, a TF will only regulate a few targets, but some global TFs can
control transcription of large sets of genes [9]. Interestingly, while TFs play a cru-
cial role in the control of gene expression, they are often found in low concentration,
possibly only a few molecules per cell [130].
Conversely, the transcription of a specific gene can be controlled by several TFs.
This important feature, termed “combinatorial regulation”, provides the cell with an
increased complexity in transcriptional regulation. Each gene can potentially pro-
cess several inputs which dictate its resulting expression profile [9]. The different
regulator molecules can act independently, if each of them affects a different aspect
of the transcriptional machinery. Alternatively, TFs are often found to form com-
plexes, either homo-dimers or hetero-dimers, thereby exerting cooperative regula-
tion on the target [9, 92]. Importantly, such cooperation implies that the regulation
only occurs when all the components of the regulatory complex are present. Yet
another mechanism of combinatorial regulation is a synergistic interaction, where
the global effect of the different TFs is greater than the sum of their individual
effects [74, 104]. Finally, different TFs can compete for the same binding site on
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Fig. 2 The different steps of the expression process of a protein-coding gene, and its possible
regulatory molecules. The colors represent the different molecule types: yellow: DNA, red: RNA,
green: protein, blue: metabolite. A gene is first transcribed into a mRNA, with the possible in-
volvement of transcription factors, long noncoding RNAs (lncRNAs) or metabolites. The mRNA
is then processed and translated into a protein; again this process can be affected by translation
factors, microRNAs (miRNAs), lncRNAs, or small molecules. The degradation of transcripts is
influenced by noncoding RNAs, RNA-binding proteins or metabolites. Once synthesised, a pro-
tein can undergo post-translational modifications, mediated by other proteins, lncRNAs or other
small metabolites. Possible modifications include conformational change, modification of specific
residues such as phosphorylation, or the formation of protein complexes. Proteins are tagged to
degradation by specific enzymes, termed ubiquitinases.
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the target promoter. The respective affinity of the different molecules for the bind-
ing sequence determines which of them preferentially occupies the promoter. These
affinities can be altered by environmental cues or changes in the promoter context
(occupancy of neighbouring sites, etc).
In addition to protein regulators, transcription can be controlled by noncoding
RNAs, whose role will be discussed later in this chapter. Furthermore, recent evi-
dence tend to suggest that small RNAs and in particular microRNAs also play a role
in transcription silencing, in addition to their impact on post-transcriptional func-
tions detailed in the following sections [20, 21]. Lastly, other features can affect
the transcription of genes. Specifically, the methylation state of DNA, and in par-
ticular of gene promoters, has been linked to gene silencing [42, 50]. A widespread
example is the inactivation of tumour-suppressor genes by hypermethylation as a
hallmark of cancer [59]. DNA methylation is controlled by an array of special-
ized enzymes. In eukaryotic cells, the chromatin structure, that is the packaging
of the DNA, affects all steps of the transcription process. This structure is dynamic
and is regulated by ATP-dependent chromatin-remodelling complexes which con-
trol DNA-histones interactions, and by histone-modification factors [67]. Histone
post-translational modifications (such as methylation, acetylation, phosphorylation
and more) greatly affect the chromatin structure, notably through the recruitment
of chromatin-remodelling complexes, or by directly influencing their interactions
with DNA. These histone marks have been found to correlate with transcription
efficiency and in some case control the access of TFs to promoters [67].
2.2 Regulation of translation
Following gene transcription and transcript processing, mRNAs are translated into
proteins by ribosomes and associated molecules. This process is also targeted for
regulation, both global and specific. The initiation of translation, that is binding of
the translational apparatus to mRNAs and recognition of the translation starting site,
is thought to be the step where most of the regulation occurs. As the specific mecha-
nisms of translation initiation differ between bacteria and eukaryotes [63, 130], reg-
ulation processes are specific to each, but similarities can be observed. Regulation
of translation offers a faster modulation of the concentration of proteins compared
to transcription regulation, as the former silences already existing mRNAs, while
with the latter these mRNAs are still transcribed until their decay [107].
As an example, during the response to a particular stress such as nutrient depriva-
tion or temperature shock, cells often undergo a global decrease of their translational
activity [35, 47, 107]. This global programming switch occurs through the control
of the availability or the activity of the translational apparatus, notably through the
phosphorylation state of eukaryotic initiation factors in eukaryotes. Such massive
translation reduction allows a decrease of the energy demand and a reallocation
of cellular resources to stress response. Specific mRNAs encoding stress-response
proteins can escape this regulation via distinct mechanisms.
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Alternatively to global programming, translation of mRNAs can be specifically
regulated for a small set of genes via the involvement of RNA-binding proteins
(RBPs) or microRNAs (miRNAs) [35, 80]. These regulatory molecules recognise
and bind to specific sequences in the target transcript, mainly situated in the untrans-
lated regions of the mRNA. RBPs mainly act through interactions with the transla-
tional apparatus, leading to the inhibition of translation [35]. miRNAs act through
the RNA-induced silencing complex (RISC) complex [54, 113]. The level of com-
plementarity between a miRNA and its binding sequence on the target transcript
specifies the triggered mechanism of regulation [130]: the extensive base-pairing
between the miRNA and its target triggers the degradation of the latter, whilst par-
tial base-pairing induces translation inhibition [56]. Interestingly, it has been shown
that in the case of miRNA-mediated translational repression, the promoter of the tar-
get gene determines the precise mechanism of action of the miRNA [62]. However
the role of small RNAs are still not perfectly clear and additional processes could
be discovered by further experimental studies [126].
It is interesting to note that the direct impact of small RNAs on the translation of
a gene can also indirectly affect other processes such as transcription of non target
genes. For example, [111] used miRNAs intervention experiments to detect their
direct impact on TFs levels, but also reported the indirect effect of these miRNAs on
the expression of theses TFs’ targets. The conservation of miRNA-mRNA sequence
match, particularly in the 3′ untranslated regions of genes enable the identification of
the miRNA-target potential pairings [33]. Conversely, evidence suggest that miRNA
synthesis can also be controlled by other RNAs [44]. We can here again raise the
concept of regulation network to start organising this knowledge. Prior interactions
can be predicted to create such networks [111, 125]. Algorithms for RNA-RNA
interaction predictions (e.g. [101]) are compared in [65]. Then molecular techniques
can confirm the putative relationships [30].
The primary sequence of the transcripts also heavily influences their transla-
tion [63]. In particular, the formation of secondary structures within the transcript
(e.g. hairpin, stem-loop, etc. which can be facilitated by the properties of the primary
sequence such as GC content for example), and specifically in regions involved in
translation initiation can impair the translation process. Specific structural features,
such as upstream open reading frames or internal ribosome entry sites can also im-
pact translation. The detailed features of such mechanisms are beyond the scope of
this chapter, and we refer the reader to [63]. However, being aware of the existence
of these mechanisms can allow the modeller to include them or at least discuss their
effect on the outcome of an analysis. In this vein, [68] postulate that protein-protein
interactions are linked to the regulation of the corresponding genes by miRNAs.
Lastly, an interesting mechanism of translation control is the regulation via “ri-
boswitches” [49, 14, 105]. A riboswitch is a regulatory sequence within mRNAs
which responds to specific cues, namely temperature or the presence of particular
metabolites. Thermo-sensors are a class riboswitches that respond to temperature
by changing their conformation, therefore modifying the translation rate of the tran-
script. Alternatively, riboswitches can detect and link to specific metabolites. This
provokes a modulated translational activity of the transcript via the modification of
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the mRNA conformation.
2.3 Regulation of mRNA decay
In addition to the elimination of defective mRNAs arising for example from tran-
scription or splicing errors, fully functional mRNAs are subject to spontaneous or
targeted degradation. Regulation of mRNA decay plays an important role in the re-
sulting transcript level. Specific degradation of transcripts can be mediated by RBPs,
or by small RNAs, namely miRNAs and small interfering RNAs (siRNAs) [47]. In-
terestingly, mRNAs encoding functionally-related proteins were shown to exhibit
correlated half-lives. This phenomenon suggests a common regulation of mRNAs
involved in similar biological processes [120, 127].
RBPs recognise and bind to specific sequences in mRNAs. It allows them to
trigger the recruitment of decay factors, ultimately leading to target degradation.
Alternatively, some RBPs have been found to stabilize their targets, protecting them
from degradation [64]. Just as factors regulating other aspects of gene expression,
RBPs can interact to exert combinatorial control over mRNA decay rates.
Alternatively, miRNAs and siRNAs can promote the decay of target mRNAs, via
interactions with RISC and possibly with other RBPs. Such a phenomenon is coined
RNA interference or RNAi [75, 113]. As mentioned previously, such degradation is
promoted by the perfect pairing of the small RNAs with the target transcript. Sev-
eral mechanisms can be involved to trigger target degradation. Possibly, interactions
with small RNAs and RISCs promote the endonucleolytic cleavage of the transcript.
Another explanatory mechanism is that the target can be directed to P-bodies, which
are small cytoplasmic granules containing RNA degradation machinery [113]. Tar-
geted mRNAs are locked in these P-bodies and consequently degraded before they
can be further processed, e.g. translated.
2.4 Regulation of protein activity
After translation, proteins are sometimes subjected to additional modifications to ac-
quire their fully functional state. These changes can be irreversible, i.e. proteolytic
cleavage of the peptidic precursor to obtain a functional protein [23, 130]. Alterna-
tively, the cell can modulate the activity of its protein pool via a number of reversible
post-translational modifications. A common mechanism is the modification by spe-
cialised enzymes of some amino acids on the protein, such as phosphorylation, oxi-
dation or acetylation [118]. In particular, phosphorylation is a common mechanism
for the activation of enzymes, TFs or other proteins. It is used in signalling path-
ways to relay extracellular messages to the nucleus, via a cascade of phosphory-
lation which activate kinase proteins [53, 69]. The endpoints of such pathways are
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generally TFs, whose phosphorylation lead to their activation and relocalisation into
the nucleus where they can modulate the expression of appropriate response genes.
Taking again the example of signal transduction in the cell, the cascade of phos-
phorylation is initiated by the activation of membrane receptors, that detect a partic-
ular signal in the environment -generally a vitamin, a hormone, or another metabo-
lite. This specific ligand binds to the receptor peptide, and triggers conformational
changes to lead to the activation of the receptor. Such activation prompted by the
binding of a small molecule is also frequently found in metabolic pathways, as a
mean to regulate the production of a specific compound [23]. Metabolites can bind
to the enzymes responsible for their synthesis in a feedback loop that auto-regulates
enzyme activity according to the abundance of this specific product. Conformational
changes resulting from ligand binding can mask or reveal the catalytic site of the en-
zyme, thereby controlling its ability to bind with its substrates.
Lastly, peptidic chains sometimes need to assemble into multimers, to form a
functionally active molecular complex [23]. Such protein complexes can be com-
posed of several copies of the same protein, or of different proteins. In the latter
case, the abundance of the complex, and hence its activity, is limited by the least
abundant species. It is an interesting mechanism of regulation of the complex activ-
ity. Information about interactions among subunits can be found in protein-protein
interaction databases (see for example [109]).
2.5 Regulation of protein decay
Cells possess several pathways for the degradation of proteins. A first mechanism
is concerned with the degradation within lysosomes, which is a non-specific pro-
cess, notably solicited in response to nutrient starvation as a rapid source of amino
acids [85]. In addition, proteins can also be specifically tagged to degradation, via
conjugation of a ubiquitin chain to the target peptide [114, 66, 130]. Tagged proteins
are recognised by cellular machineries termed 26S proteasomes and subsequently
degraded. This ubiquitin-proteasome pathway provides the cell with a way to rapidly
control a regulatory process by degrading its effectors. It is notably involved in the
regulation of transcription via degradation of specific TFs [66].
The addition of ubiquitin on target proteins is mediated by the E1, E2 and E3
enzymes. The different isoforms of the E2 and especially E3 family confer a great
specificity to this process, as each isoform can recognise different substrates. Addi-
tionally, some structural properties of proteins can impact their affinity as substrate
for the ubiquitin-proteasome pathway. For example, a member of the E3 family
recognises particular amino acids at the N-terminal position of proteins, in what is
call the N-end rule pathway [66]. The nature or accessibility of specific residues
can also impact the ability of ubiquitination enzymes to recognise and tag target
proteins.
It is interesting to note that the ubiquitin-proteasome pathway is able to degrade
only a subunit of a given protein, for example to produce a functionally active prod-
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uct or on the contrary inactivate the protein. This is the case for the NF-κB TF,
which is bound by its inhibitor, IκB [114]. In response to a specific signal, the com-
plex is ubiquitinated, and the proteasome cleaves the IκB, thereby freeing the TF,
which, in turn, is relocated into the nucleus to trigger the required cellular response.
Quantitative measurements have highlighted the coupling between synthesis and
decay rates of proteins. As for transcripts, these parameters seem to be correlated
among proteins intervening in common complexes or functions. It appears that pro-
teins involved in housekeeping functions are relatively stable, with a high produc-
tion rate, leading to high concentrations in cells. On the contrary, regulatory proteins
tend to be less synthesised and more rapidly degraded. This is consistent with the
observation that they are often found in a low concentration in the cell [12, 116].
2.6 The role of genetic variation
In addition to diverse cellular molecules which perform a wide range of regula-
tory activities, the DNA sequence itself plays a role in regulating gene expression.
Regulatory sequences present in the promoter region of genes or in the transcribed
or translated sequences dictate the set of molecules and complexes that control the
expression of these genes. These sequences target transcripts or corresponding pro-
teins for particular regulatory mechanisms. Their affinity for regulators control the
strength of this regulation. The impact of genetic variation on gene expression has
been studied, notably via expression quantitative trait loci (eQTL) studies. eQTLs
are genomic regions within which genetic variability is associated with variation
in the abundance of a particular transcript [38]. More generally genetical genomics
studies (also termed cellular genomics) [57, 34] analyse how polymorphisms lead
to variation in molecular traits, such as mRNA, protein or metabolite profiles.
Using additional genomics data such as DNA methylation state or chromatin
accessibility, researchers are now focusing on identifying the specific mechanisms
which relate genetic variants to response molecular traits. At the transcript level,
evidence tends to show that eQTLs lead to transcript abundance variability mainly
via their impact on TF binding [115, 34, 2]. Polymorphisms at these loci also affect
other aspects of transcription, but it is yet to be determined if it is a direct con-
sequence of genetic variation or merely an indirect effect of variation in TF bind-
ing efficiency [87]. Some polymorphisms have also been shown to affect mRNA
degradation, notably through modification of miRNA binding sites, or other post-
translational mechanisms [34, 87]. In a groundbreaking effort, [13] discovered in-
structions encoded in the sequence itself to regulate gene activity. The nucleotide
composition can be directly read to accurately decipher biological mechanisms.
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2.7 An example: long noncoding RNAs
After this review of the possible interactions regulating the different aspects of the
gene expression process, we now turn our attention to a specific class of regulators
whose role in the different biological processes mentioned earlier is just starting to
be appreciated. Indeed, the functional importance of long noncoding RNAs (lncR-
NAs) was only hinted at when experimental studies of genome-wide transcription in
cells revealed that a large fraction of the genome is transcribed, even if only a small
amount actually encodes proteins [96, 91]. This discovery shook the traditional cen-
tral dogma of biology stating that RNAs’ primary role is to serve as messengers to
produce functionally active proteins. On the contrary, as highlighted above, noncod-
ing RNAs are now known to play important regulatory roles. While we now have a
fair understanding of small noncoding RNAs (e.g. miRNAs, siRNAs, etc) and the
associated biological processes, lncRNAs (exceeding 200 base-pairs, as an arbitrary
defining threshold) remain for most of them terra incognita. In particular, the extent
of their functional role is yet to be determined, and there is still debate about whether
the RNA molecule itself has a functional role or if only the physical changes trig-
gered by its transcription (e.g. chromatin opening, helix unwinding, etc) impacts the
transcription of neighbour genes while the produced transcript is useless [119, 130].
This is notably due to the fact that their primary sequence is less conserved than
those of protein-coding genes [79, 91]. Nonetheless, experimental studies put us on
the track of lncRNA involvement in a great variety of biological processes, from reg-
ulation of gene expression and chromatin state to genomic imprinting, in particular
X chromosome silencing [89, 96, 91]. In addition, characteristic features of RNA
make them well-suited for regulatory functions: their fast kinetics with no need for
translation and their rapid degradation is particularly convenient for a fast and tran-
sient response to external stimuli. Moreover, their ability to bind DNA and RNA
allows them to interact with both genes and transcripts [119, 36]. In this section,
we briefly present the diverse roles played by lncRNAs in the regulation of gene
expression. For a more thorough review about the biological roles of lncRNAs, we
refer the reader to the review by Geisler et al. [36].
One of the primary focuses of early studies about lncRNAs was their involve-
ment in chromatin modelling [96], ultimately resulting in the modulation of gene
expression. lncRNAs can act as scaffold which bring together different chromatin-
remodelling proteins and to assemble them into a functional complex [119, 96].
Alternatively, they can guide such proteins to a target location, triggering changes
in chromatin structure [79]. An interesting mechanism of action follows the tran-
scription trail of the noncodingRNA which influences the chromatin state. It conse-
quently impacts the transcription of neighbouring genes [36].
lncRNAs can also enhance or repress the initiation of transcription via interac-
tions with the basal transcriptional machinery. For example as a response to heat
shock, the interaction of a specific lncRNA with RNA polymerase II triggers the
inhibition of target genes [79, 36]. Additionally, lncRNAs can target TFs and modu-
late their activity, by directly prompting conformational changes, by recruiting TFs
onto the target promoter, or by withholding the TFs away from their targets [130].
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lncRNAs are also involved in other steps of the gene expression process. In
particular, they can influence mRNA processing, in particular mRNA splicing and
editing [79, 36]. Some lncRNAs can impact translation efficiency of their target
transcripts, through mechanisms which are still not totally clear [36]. They also
putatively control RNA stability, either by recruiting specialised degradation ma-
chinery to the transcript, or by competing with miRNAs for binding sites. In the
latter case, lncRNAs play a protecting role for mRNAs in preventing or delaying
their degradation. For example, they can lure miRNAs to competitively bind to the
same targets [119, 36]. Finally, lncRNAs can assist in protein binding to modulate
their activity. Target proteins can be TFs, chromatin remodellers, or other regulatory
molecules.
While a few well-studied lncRNAs provide evidence for a functional role of these
transcripts, a lot remains unknown about them. In particular, it is important to keep
in mind that the functional roles described above apply to a few number of char-
acterized lncRNAs, and it is possible that a fraction of these transcribed noncoding
genes are the result of transcriptional noise or experimental artefacts [89]. The mod-
eller has the choice to include such information for a few annotated lncRNAs only,
or to include the different putative roles, e.g. in a Bayesian framework.
As demonstrated throughout this section, the expression of genes is subject to a
tight regulation from which arises great biological complexity. We now embrace the
point of view of the statistical modelling of such biological systems. In particular,
we discuss the different aspects of the construction of a model that must be carefully
thought out in order to faithfully describe the biological processes under study.
3 Modelling gene expression
Statistical models of GRNs aim at reproducing biological systems from a mathemat-
ical perspective to permit, inter alia, the simulation of their dynamical behaviour.
A number of models for the simulation of expression data have been proposed in
the last decades; an overview of the principal algorithms and their key features is
presented in Table 1. However, the design of such simulation tools is far from triv-
ial. First and foremost, the model must be a faithful representation of the biologi-
cal system, from the general topology of the underlying regulatory network to the
quantitative regulation exerted on the genes and gene products. In addition, differ-
ent mathematical frameworks can be used for the dynamic simulation of expression
profiles, each of them carrying its own set of assumptions and limitations.
With all these considerations in mind, the next section provides a thorough re-
flection on the different features to examine when building a simulation network as
well as a contrast of existing methods to simulate data from an in silico network.
The general pipeline for the construction of a simulation algorithm can be found in
Figure 3.
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Fig. 3 The different steps of an algorithm for expression data simulation. Each of these steps will
be detailed in the referred sections.
3.1 Topological properties of regulatory networks
A crucial step in simulating expression data from regulatory networks is the selec-
tion of a network topology that defines the interactions among the molecules. In a
graphical representation of a GRN, nodes typically represent genes and their prod-
ucts, while edges correspond to regulatory interactions between molecules. Edges
carry the direction of the regulation, that is, which nodes are regulators and which
nodes are target molecules. The choice of the topology of a GRN is by no means
an easy task. A first and simple approach for network modelling is to represent reg-
ulatory networks as random networks [31, 61] (also termed Erdo¨s-Re´nyi graphs)
in which each pair of nodes has the same probability of being connected. This
model was and is still used for expression data simulation. However topological
analysis of pathways recovered from model organisms highlighted the existence of
specific structural properties among biological networks, owing to the evolutionary
constraints that shaped them. Algorithms for the generation of synthetic networks
with similar properties where developed to construct more realistic models of bi-
ological systems. Interestingly, a number of these properties are shared with non
biological systems such as the Internet or social networks [11]:
• Small-world property: Networks are characterized as small-world if their aver-
age path length1 between any two nodes is small. It has been shown that most
biological networks exhibit such a property (see for example [58, 117, 3]). This
implies that components of biological networks are easily reachable from any
other node, which allows a rapid response to stimuli or perturbations [3]. Syn-
thetic random small-world networks are also referred to as Watts-Strogatz net-
works [121].
• Scale-free property: When studying the in- and out-degree distribution of (di-
rected) biological networks, i.e. the the number of incoming and outgoing edges
respectively, it has been noted that this distribution can often be modelled with a
power-law distribution [10, 4]. More specifically, the probability of a node to ex-
hibit k edges is P(k) ∝ k−λ . An implication is that the majority of nodes interact
only with a few partners, while a small number of nodes, called hubs, are highly
connected. Metabolic pathways were shown to have this property [58, 117], and
1 The path length between a pair of nodes is defined as the length of the shortest path connecting
the two nodes.
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so were GRNs [32]. For both types of networks, the scale parameter λ usually
ranges between 2 and 3 [93, 11]. However recent findings suggest that for some
organisms the in-degree distribution of transcriptional networks is not scale-free,
as detailed below. An algorithm for generating random scale-free networks has
been proposed by Albert-Baraba´si [4]. Bolloba´s [17] presented a directed version
of scale-free networks, where both the in- and out-degree distributions are power
laws, with possibly different λ coefficients.
• Exponential distribution of the in-degree distribution (for transcriptional net-
works): alternatively to the scale-free property, studies [43, 9] suggested that the
in-degree distribution of GRNs for some organisms is better fitted by an expo-
nential distribution, i.e. P(k)∝ 1λ e
− kλ . This implies that genes are regulated only
by a few (generally up to three) TFs [11], a more plausible configuration in bio-
logical networks.
• Modularity: real networks have a tendency to form groups of highly intercon-
nected nodes, referred to as modules. This modular organization is characterized
by a high average clustering coefficient [121, 117]. The clustering coefficient C
of a node is a measure of the degree of connectivity among the direct neighbour-
hood of this gene. This property is important for biological systems, as it implies
that biological networks are organised into relatively independent modules that
each perform a distinct biological function. While inside a module the compo-
nents are tightly linked, modules are only weakly connected with each other. This
last property ensures to some degree robustness to the network, as disruption in
one module is less likely to severely impair the rest of the network [11]. Methods
to identify modules within pathways [102] could clearly inform gene network
inference and this information should not be ignored when exploitable.
• Hierarchical organization: contrary to random or scale-free networks for which
the average clustering coefficient decreases with the number of nodes in the net-
work, biological networks are characterized by a system-independent average
clustering coefficient [93]. Moreover, the clustering coefficient of a node is a
function of its degree [93], since: C(k) ∝ k−1. This last property is a character-
istic of a hierarchical organization of the network. This important mathematical
concept allows us to reconcile the scale-free property and modular nature of bi-
ological systems. Indeed, it stresses that nodes of low connectivity tend to be
found in clusters, while hub nodes constitute the junction between modules. It is
to note that hub nodes will less likely be connected to each other.
• Over-representation of network motifs: another important feature of biological
networks is the abundance of small regulatory motifs [83, 106], that are recur-
ring and non-random building blocks of the global topology [129]. They confer
specific advantages to the system by encoding well-defined local dynamic be-
haviours in response to perturbations, for example buffering intrinsic stochastic-
ity or on the contrary amplifying an external signal to trigger a cellular response
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[6]. One well-known example is the negative feedback loop, in which the product
of a gene regulates its own transcription [98]. This auto-regulation feature allows
the control of the natural fluctuation in the concentration of the gene product, as
its synthesis is directly coupled to its abundance [6]. Another famous example is
the feed-forward loop, who can simultaneously process two different stimuli and
whose output depends on the nature (activation or repression) of the regulatory
interactions composing the motif [71]. A detailed quantitative analysis of such
motifs and the advantages they provide to the system can be found in the book
[5].
As pointed out by Przulj et al. [90], such studies are based on our current and
incomplete knowledge of biological networks. Despite this limitation, algorithms
for the generation of graphs mimicking these structural properties have been pro-
posed, for a more accurate representation of biological networks. In addition to
the three most commonly used Erdo¨s-Re´nyi, Albert-Baraba´si and Watts-Strogatz
networks, Haynes et al. [48] implemented a method for simulating topologies with
scale-free out-degree distribution and any desired in-degree distribution. Di Camillo
et al. [27] proposed a hierarchical modular topology model that generates networks
displaying scale-free degree distribution, high clustering coefficient independent of
the network size, and low average path length. However, to offer flexibility in the
simulation, most simulators offer as an option for the user to choose among the
different network topologies cited above. It becomes therefore possible to assess
the impact of the underlying topological properties on the performances of a given
network inference algorithm.
The main drawback of in silico networks is that none of the aforementioned
network simulation methods are able to simultaneously reproduce all characteristic
features of real networks [25]. Another approach for graph generation has hence
been proposed. It relies on the use of real biological networks determined experi-
mentally. They are used as seeds from which sub-networks are sampled. Van den
Bulcke et al. [25] proposed two sampling approaches: the cluster addition method
and the neighbour addition method. Building up on this idea, Marbach et al. [73]
further refined the approach by forcing the preferential inclusion of modules in the
sampled sub-networks. This module extraction method ensures a fair representation
of network motifs in the generated topology, as observed in biological networks.
Such an approach of sampling from real networks ensures a more faithful picture
of biological pathways. Again, this is contrasted by [25], as the real network sam-
pling strategy relies on our current knowledge of regulatory networks, which is still
incomplete, and probably biased towards well studied pathways. Lastly, Haynes et
al. [48] pointed out that networks generated from the same source network may not
be “statistically independent” as they may overlap and thus provide redundant infor-
mation. It is particularly true when sampling a large number of subnetworks from a
single source, as most of them will share common nodes and interactions.
16 O. Angelin-Bonnet, P.J. Biggs, M. Vignes
3.2 Mathematical frameworks and regulation functions
Once the network topology is set, the next step for data simulation is to decide on
the mathematical framework to be used to compute the profiles of gene expression,
which will impact the choice of regulation rules for the system. It is important to
carefully consider the different options, as each formalism carries a number of un-
derlying assumptions about the represented system. Moreover, different levels of
precision about the system can be integrated. Choices depend on many factors to
achieve a balance between the level of required details to make the simulations more
realistic, and the computational efficiency desired. While it is not our goal to offer an
extensive comparison of all the possible formalisms, we emphasize here the differ-
ence between the two mainstream formalisms in existing simulators of expression
data: the continuous-and-deterministic and discrete-and-stochastic frameworks. We
present the basic concepts of these approaches, and highlight the different hypothe-
ses about the biological system underlying each model. For a more detailed and
mathematically-centred review of these and other formalisms we refer the reader to
[24] and [51].
3.2.1 The continuous and deterministic approach
The continuous and deterministic approach is particularly suited to simulate data
that resemble those resulting from a transcriptomics (or other ’omics) experiment.
The output is a series of continuous variables, as opposed to cruder logical models
that predict the activation state of each gene as a binary outcome. In such determin-
istic models, biological molecules are represented as time-dependent continuous
variables. Typically xi(t) represents the concentration of entity (or species) i at time
t. Variation in the concentration of a species over time is assumed to occur in a con-
tinuous and deterministic way. Such changes are modelled as differential equations,
in the form of:
dxi
dt
= fi(X), (1)
where X refers to the state of the system (that is the concentration of all the species
present in the system), and fi represents the change in the concentration of species
i as a function, often non-linear, of the global state of the system. More specifically,
in the case of a chemical species and associated reactions, fi(X) can be written as:
fi(X) = vi(X)−di(X), (2)
where the vector vi(X) represents the synthesis rate for species i, while di(X) mod-
els its decay rate (due to degradation, dilution, use as a reactant, etc.). Both rates
are themselves expressed as a function of the system state. The ensemble of reac-
tions occurring in the network provides a set of coupled differential equations that
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describe the evolution of the state of the system through time. Except for simple net-
works, with only a few molecules and/or linear interactions, an analytical solution is
often intractable. It is however possible to integrate the model in order to compute a
numerical solution. A plethora of differential equation system solvers are available
in different programming languages (for example the deSolve package for R, the
dsolve function of the Symbolic Math toolbox for Matlab or Berkeley Madonna).
Regulatory molecules for species i appear on the right-hand side of Equations 1
and 2. They impact the abundance of their target species i via regulation of the
different expression steps, as we discussed them in Section 2. The regulation of a
particular reaction is hence modelled via a reaction rate law, which dictates how
the rate of the regulated reaction (e.g. vi or di) evolves with the concentration of the
different regulatory molecules. The vast majority of proposed simulation algorithms
focus on the representation of transcription regulation, but similar consideration can
be applied to any type of regulation (translation, degradation...). Two important fea-
tures must be considered in order to fully characterize a reaction rate law: (i) the
quantitative relation between a regulator abundance and the resulting reaction rate,
and (ii) the combination scheme of the individual effects of different regulators on
a common target. In the following we will discuss these two aspects, using the ex-
ample of the regulation of gene transcription.
We first consider gene i whose transcription is regulated by a single molecule j.
Several choices are possible with regard to the resulting effect of the regulator abun-
dance on the transcription rate. A simple approach is to consider that the regulation
effect increases linearly with the regulator concentration [26, 128] (Figure 4 a), as
follows:
fi(x j) = β · x j (3)
where fi represents the transcription rate law of gene i, which depends on the con-
centration of the regulatory molecule x j. In addition to the fact that this represen-
tation ignores any saturation effect arising from the limited amount of cellular re-
sources and the maximum possible number of simultaneous transcription events,
such a linear relationship can produce concentration values out of the plausible
range of abundance encountered in vivo, possibly leading to infinitely large popula-
tions, which is biologically irrelevant. It is hence important to construct biologically
credible reaction rate laws that result in realistic regulation strength and concentra-
tion values.
Alternatively, a Hill function (Figure 4 b) can be used to model the impact of an
activator on the gene transcription:
fi(x j) =
x
ni j
j
x
ni j
j +K
ni j
i j
, (4)
or, for a repressor:
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fi(x j) =
K
ni j
i j
x
ni j
j +K
ni j
i j
, (5)
where Ki j represents the concentration of regulator j required to obtain a half-
maximum effect on the transcription rate of gene i, and ni j controls the steepness
of the regulation. It must be noted that Ki j must be non negative as it accounts for
a concentration, and ni j ≥ 1. Indeed, when ni j = 0 the resulting reaction rate law is
constant. This sigmoid function accounts for the saturation of the regulatory effect:
after the regulator concentration has reached a certain level, any further increase
in this concentration will only result in a minimal change in the transcription rate.
Additionally, tuning the parameter ni j enables to represent a variety of regulation
behaviours, from a quasi-linear (ni j small) to a step-like (ni j high) function. Fur-
thermore the use of a Hill function law can be justified by a thermodynamic model
of the binding of TFs on the target promoter [1, 16]. Considering that the mean tran-
scription rate of a gene is proportional to the saturation of its promoter by TFs, the
effect of the regulator can be further refined as:
fi(x j) = α0
[
1+(FCi j−1)
x
ni j
j
x
ni j
j +K
ni j
i j
]
, (6)
where α0 represents the basal transcription rate of the target gene in absence of the
regulator, and FCi j the maximum fold-change2 of gene expression induced by the
regulator. Details of this computation can be found in the Supporting Information
of [72]. It is straightforward to deduce the transcription rate law for a gene whose
expression is controlled by an inhibitor, as the resulting maximum fold-change is
FCi = 0:
fi(x j) = α0
[
1− x
ni j
j
x
ni j
j +K
ni j
i j
]
(7)
Such representation is massively used in simulator algorithms, although with some
variations [78, 25, 100, 48, 45, 103, 88]. For example, the transcription rate law
represented in Equation 6 can be adapted to account for a gene that is not expressed
in the absence of its activator.
Taking the approximation that ni j → ∞, it is possible to simplify this Hill func-
tion, and model the transcription rate law as an on-off switch, where the maxi-
mum effect of the regulator on the transcription rate occurs as soon as the regulator
molecule level exceeds a certain threshold. Below this threshold, no regulation is
observed. Such representation is described by a step function (Figure 4 c):
2 The fold-change of a gene is defined as the ratio of its transcription rate in the presence of a
high concentration of regulatory molecules over its transcription rate in absence of regulator. From
equation 6 it is easy to see that the transcription rate of gene i tends towards α0 ·FCi j when x j
becomes large, hence the fold-change tends to α0·FCi jα0 = FCi j .
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fi(x j) =
{
α0 x j < Ki j,
α1 x j ≥ Ki j.
α0 can be set to 0, to model the case of a gene that is not expressed in absence of
its regulator. This simplification provides the basis for piecewise differential equa-
tions [24]. It allows us to model a non-linear interaction even if the kinetics of the
regulation are not known in detail.
Fig. 4 Possible transcription rate law functions. a) The rate law accounts for a linear dependence
between the concentration of the regulator (x) and the transcription rate of the target gene ( f (x)).
b) The Hill function accounts for the saturation of the regulation: when x is high, the variation
of the transcription rate tends to 0. The parameter K corresponds to the concentration at which
the regulatory molecules induce a transcription rate equal to half its maximum value. c) With a
step function, the target gene is only transcribed when the concentration of the regulator exceeds a
certain threshold, here K.
Once the quantitative effect of a regulator has been chosen, one must consider the
overall effect of several regulators targeting a common gene. Indeed, different com-
binatorial regulations can be modelled. A simple example is to assume that different
regulators impact the expression of the target gene independently of each other. This
approach has been used by Mendes et al. [78]. For an independent combinatorial ef-
fect model, the resulting regulation effect of all regulators is equal to the product3
of the individual effects of each regulator on the transcription rate.
Alternatively, the different TFs can assemble into a complex that will bind to the
target promoter to regulate transcription. In this case, the resulting regulation effect
will be limited by the least abundant regulator species. An example can be found in
[100], in which different TFs can assemble into cliques which in turn can form TF
3 The use of the product, rather than the sum, ensures that if the concentration of a repressor is high
enough to silence the gene (resulting in an individual effect close to 0) the overall transcription
rate will also tend to 0 regardless of the quantity of activators present. It also implies that the
overall fold-change obtained for large quantities of the different activators is the product of the
fold-changes individually induced by each activator, which is justified thermodynamically in [15]
and [16].
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complexes regulating the target gene. The resulting translation rate law is therefore
equal to 0 as soon as the concentration of one of the TFs reaches 0, as it is then not
possible to form a functional complex.
An interesting approach has been proposed by Di Camillo et al. [27]. It uses
fuzzy logic to represent the possible combinatorial interactions between different
regulators. The advantage of such an approach is that it combines the Boolean logic
functions (AND, OR, NOT, etc.) well suited to describe combinatorial behaviour
with continuous regulation, as the output of fuzzy logic functions is a continuous
value. Given a continuous input, that is the concentration of each regulator, the
fuzzy logic applies a set of functions such as min, max, or ∑ (sum) to output the
level of regulation commonly achieved by the different regulators. Di Camillo et
al. hence represents “cooperation” (for which the regulation is only achieved in the
presence of all the required regulators) as a min function applied to the set of regula-
tor concentrations. Similarly, synergistic behaviour, direct inhibition or competition
are modelled with fuzzy logic functions.
Deterministic models are traditionally used for the simulation of expression
data [78, 25, 100, 27, 46, 48, 72] (see Table 1). However, despite its broad use,
the deterministic formalism presents several limitations, which relates to the under-
lying hypotheses about the biological system depicted. In particular, the assumption
of continuous change in species concentration is only valid for a macroscopic de-
scription of biological systems [24], i.e. when the number of molecules in the cell is
large enough so that species concentrations can be considered to vary continuously
when a discrete number of molecules is actually added/withdrawn from the system.
When the abundance of a species reaches low values (defined as a thousand or less
by [19]), this assumption does not hold anymore, and it is more correct to represent
this abundance by a discrete molecule count. Moreover, the deterministic assump-
tion can be questioned, particularly for small systems, given the fluctuation in the
timing of biochemical reaction events [24]. Indeed two identical genes with the same
transcription rate will not produce exactly the same number of transcripts during the
same time period, due to the apparent stochasticity of biological events. While this
fluctuation can be averaged out for highly abundant species, it is more difficult to ig-
nore it for species with only a few molecules per cell. As numerous studies have un-
derlined the importance of stochasticity in biochemical systems [99, 76, 123, 124],
it can be preferable to explicitly model stochasticity in the simulation.
3.2.2 The discrete and stochastic approach
To overcome the limitation of continuous and deterministic models, in particular
for modelling small systems, a discrete and stochastic representation of biological
systems has been proposed. It must be noted that even if the continuous and deter-
ministic approach and the discrete and stochastic framework are commonly referred
to as respectively deterministic and stochastic models, there exists representations of
biological systems that are either discrete and deterministic (e.g. Boolean networks)
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or continuous and stochastic (e.g. Chemical Langevin Equation, discussed later).
One must hence keep in mind that continuous (resp. discrete) does not necessarily
imply deterministic (resp. stochastic) as the first terms refer to the representation of
species abundance while the latter corresponds to the variation of the system state.
In the discrete and stochastic framework, the state of the system corresponds to
discrete values accounting for the number of molecules of each species present in the
system. While the vast majority of deterministic approaches are species-centred, i.e.
one differential equation represents the evolution of one species abundance through
time, stochastic models often rely directly on the biochemical reaction formalism.
These reactions can be schematically represented in the form:
Substract 1+Substract 2 Reaction rate−−−−−−−→ Product 1
Or, in the context of gene expression:
Promoter+TF
c1−→ Active promoter
Active promoter
c2−→ Active promoter+mRNA
Each reaction is characterized by:
• A stoichiometry vector v j which represents the change in abundance of the dif-
ferent species resulting from one firing (i.e. one occurence) of the reaction. Neg-
ative and positives indices correspond respectively to reactants and products of
the reaction.
• A propensity function a j(X), with a j(X)τ representing the probability that the
reaction will occur in the next time step [t, t + τ] given the system state at this
time t. The rate a j depends on the current state of the system. If c j is the constant
probability that one molecule of each of the r reactant species Si, 1≤ i≤ r collide
and undergo the reaction in the next time unit, then a j = c j.∏
r
xr. Generally the
number of reactants per reaction is limited to one or two, as a reaction involv-
ing more substrates can be decomposed into a set of elementary reactions [41].
Taking the example reactions above, the propensity function of the binding reac-
tion of one TF molecule on the promoter will be: c2 · xPromoterxT F . It is therefore
possible to link deterministic and stochastic rate constants, as shown in [41].
The system state change is then computed in terms of probability by the Chem-
ical Master Equation (CME), which computes the evolution of the probability that
the system is in state X through time. For details about its computation, we refer
the reader to the review by El Samad et al. [29]. An analytical solution of the CME
provides the probability density function of the system state X(t). However, as for
deterministic models, the computation of an analytical solution is impossible ex-
cept for quite simple systems. Therefore, one way to study the behaviour of the
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system is to construct numerical realizations of the CME. One of the most used
method is Gillespie’s Stochastic Simulation Algorithm (SSA) [39]. SSA increments
the system state at discrete time points, by randomly selecting the next reaction
to fire, according to the propensity function of every possible reaction, as well as
simulating the event (reaction occurring) time [39, 29]. Several exact (i.e. simulat-
ing every single reaction) alternatives to the original algorithm (the so-called direct
method) have been proposed, such as the next-reaction method [37], the sorting
direct method [77], and others (see [41, 86] for a review). However exact algo-
rithms are limited by their computational cost which renders the simulation of large
systems intractable. Several approximation methods have been proposed, and have
been thoroughly discussed [112, 29, 60, 123]. Approximation simulations such as
the very popular tau-leaping method considerably reduce the simulation time, but at
the expense of a hardly estimable loss of accuracy [123].
Stochastic discrete simulations offer a different perspective on the modelling of
regulation compared to the deterministic continuous approach, as they explicitly
model the binding of regulator molecules on the target promoter. Taking the example
of TFs regulating the expression of a given gene, a stochastic model can represent
the binding of regulatory molecules on the promoter of the target gene as follows:
Promoter+TF→ Active promoter
Active promoter→ Promoter+TF
Active promoter→ Active promoter+mRNA
In this model, a TF must be bound to the promoter for a transcription event to
occur. Using this representation, it is easy to represent the different combinations of
TFs bound to the promoter, and the transcription rate associated with each state. The
possible combinatorial regulation effects can also be explicitly stated. For example,
reactions can be added to encode the formation of a regulatory complex from the
different TFs and to encode the binding of the complex on the target promoter.
The advantage of a stochastic model as opposed to its deterministic counterpart is
its ability to fit more precisely to the natural variation inherent to biological systems.
This biological fluctuation can be crucial for understanding certain systems, as il-
lustrated by El Samad et al. [29] that present several examples where a deterministic
model fails to correctly predict the system behaviour. As for its deterministic coun-
terpart, the stochastic framework implies a number of hypotheses on the represented
system. In particular, it relies on the essential assumption that the system is well-
stirred, that is, the molecules are homogeneously spread in the volume. Moreover
the simulation of temporal trajectories is computationally heavier as each reaction
(in the case of exact simulation algorithms) or group of reactions (for approximate
methods) is simulated. This is especially true for a system with a high number of
molecules or reactions with large value propensity functions, as both factors imply
high firing rates.
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3.2.3 Bridging the gap
Starting from a stochastic model and in particular the CME representation of a given
system, it is possible by means of simplifying assumptions to obtain the correspond-
ing continous deterministic model. As stated in the tau-leaping approximation of the
SSA, under the assumption that the time step τ in the simulation is small enough so
that the propensity functions of the different reactions stay approximately constant
during the interval [t, t+ τ], the number of reactions occurring during that time step
can be modelled as a Poisson process [29, 51]. Consequently, it is possible to sample
the number of occurrences of each reaction with propensity function a j from a Pois-
son law with parameter a j · τ . Moreover, if the time step τ is at the same time large
enough so that each reaction fires more than once during the interval [t, t + τ] (usu-
ally feasible in systems where the concentration of species is large enough [29]), the
system can be represented by a set of stochastic differential equations, termed the
Chemical Langevin Equation (CLE) [40, 29]. In the CLE, the population of each
species evolves in a continuous but stochastic manner, with the stochastic variation
due to each reaction being proportional to the propensity of the reaction. As a conse-
quence, the number of occurrences of a reaction with a high rate will have a higher
variance than that of a reaction with a small reaction rate.
By further assuming that the abundance of each species is high enough, the
stochasticity can be neglected, and the system is reduced to the Reaction Rate Equa-
tion (RRE) [29, 51], that is a set of differential equations:
dX(t)
dt
=
M
∑
j=1
v j ·a j(X(t)) (8)
In this equation, the change per time unit in the concentration of a given species
amounts to the sum over all reactions of the change in the species abundance trig-
gered by one firing of the reaction (i.e. v j), weighted by the rate of the reaction
(i.e. the probability that the reaction will fire in one time unit, a j). As highlighted
by Higham [51], it is important to keep in mind that the solution of a deterministic
model or RRE obtained by simplifying a stochastic model is not equivalent to an
average of many numerical realisations of the corresponding stochastic model. It is
rather a limit towards which these realisations tend when the different simplifying
assumptions are fulfilled.
This connection between the stochastic and deterministic frameworks has been
leveraged in the case of multi-scale systems, which are systems in which both slow
and fast reactions and/or both low- and high-abundance species are present [29].
This situation can be encountered for example when simulating gene expression
and metabolic reactions in a single model. On one hand, gene expression is a slow
process involving genes that are present in only one or two copies per cell, and
TFs whose abundance can be as low as a dozen of molecules only. On the other
hand, metabolic reactions are fast enzyme-catalysed processes and involve highly
abundant metabolic species. The issue with such systems is that some but not all
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reactions could be represented by a deterministic process, while the rest requires a
stochastic modelling. In such cases, the SSA performs poorly because of fast re-
actions and highly abundant species which monopolise most of the computational
time. On the opposite, deterministic models provide a poor approximation of slow
reactions and low abundant species. Several hybrid methods have hence been pro-
posed. Their strategy is to split reactions and/or species in two sets of slow and fast
reactions/species, and to use the most appropriate representation to model each set
(see [86] for an overview of existing methods). This principle notably underlies the
slow-scale SSA algorithm [18]. The interested reader is referred to [29, 86] for more
details.
3.3 Model simplifications
In addition to the mathematical framework they employ, existing simulators of ex-
pression data differ by a number of assumptions they make. Indeed, while it is cru-
cial to accurately represent biological processes, our incomplete knowledge about
the detailed mechanisms dictates the use of assumptions and simplifications in the
models. These simplifications also arise from the desired level of complexity and
the need for computational efficiency.
An important aspect to consider when designing a model is the type of molecules
one wishes to represent. Early models were restricted to the simulation of the tran-
script levels only (see Table 1), and used the concentration of mRNAs as a proxy
for the activity of their protein product. Such an assumption was justified by the
inability to experimentally measure protein concentration [27]. However, as shown
earlier in this chapter, a number of regulations occur post-transcriptionally. This
certainly impacts protein abundance and/or activity without being reflected at the
level of corresponding transcripts, except when the expression of a coding gene is
linked to the activity of its corresponding protein via a feedback circuit. In partic-
ular, many studies revealed a generally weak not to say poor correlation between
transcript and protein profiles [47, 116]. Such results suggest the need for more re-
alistic models in which proteins are also included as the direct actors of transcription
regulation. Some models already include the protein level (see Table 1). The inclu-
sion of other regulatory molecules, and in particular the noncoding yet very likely
regulatory [122, 84, 52] fraction of the transcriptome could also be an interesting
development. In addition, post-transcriptional regulations are traditionally overseen
in expression simulation methods. Accounting for them would result in an increased
complexity of the underlying mathematical models, but would pave the way for en-
hanced realism of simulated data.
Biological processes are not instantaneous. Time delays exists between for ex-
ample transcription initiation and the release of a fully functional mRNA ready to be
translated. Such delays have been mostly ignored, to the exception of SGNSim [94]
(implemented in the R package sgnesR [110]). These stochastic models use a ver-
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Simulation
method
Network
topology
Mathematical
formalism
Simulated
molecules
Simulated
reactions
Mendes et al.,
2003 [78]
• Random
• Small-world
• Scale-free
• Regular grid
ODEs mRNAs
• Transcription (regulated, Hill
function)
• mRNA decay (1st order process)
Van den Bulcke
et al., 2006
[25]
- SynTReN
Sampling from
source network
ODEs
(steady-state) mRNAs
• Transcription (regulated, Hill
and Michaelis-Menten functions)
• mRNA decay (1st order process)
Ribeiro et al.,
2007 [94]
- SGNSim
User-defined
Time-delay
stochastic
model
Gene promoters,
mRNAs,
proteins,
RNA
polymerase,
ribosomes
• Transcription (different transcri-
ption rate for each promoter state)
• Translation (1st order process)
• mRNA and protein decay (1st
order processes)
Roy et al., 2008
[100]
- RENCO
• Scale-free
(protein-protein
interaction)
• Exponential
degree distribution
(transcription
network)
ODEs mRNAs,proteins
• Transcription (regulated, Hill
function)
• Translation (1st order process)
• mRNA and protein decay (1st
order processes)
Di Camillo et al.,
2009 [27]
- NETSim
Hierarchical
modular topo-
logy model
ODEs mRNAS
• Transcription (regulated, fuzzy
logic)
• mRNA decay (1st order process)
Haynes et al.,
2009 [48]
- GRENDEL
Distinct in-
and out-degree
distribution
ODEs
mRNAs,
proteins,
environ-
ment
• Transcription (regulated, Hill
function)
• Translation (1st order process)
• mRNA and protein decay (1st
order processes)
Hache et al.,
2009 [46]
- GeNGe
• Random
• Scale-free
• Regulatory motifs
• User-defined
ODEs
mRNAs,
proteins,
RNA polymerase,
ribosomes
• Transcription (regulated, Hill
function)
• Translation (1st order process)
• mRNA and protein decay (1st
order processes or Michaelis-
Menten decays)
Schaffter et al.,
2011 [103]
- GeneNetWeaver
Module extraction
from source network
Chemical
Langevin
Equation
mRNAs,
proteins
• Transcription (regulated, Hill
function)
• Translation (1st order process)
• mRNA and protein decay (1st
order processes)
Pinna et al.,
2011 [88]
- SysGenSIM
• Random
• Scale-free
• Random modular
• Modular with
exponential in-degree
and power law out-
degree
ODEs
mRNAs,
cis- and
trans-eQTLs
• Transcription (regulated, Hill
function)
• mRNA decay (1st order process)
Tripathi et al.,
2017 [110]
- sgnesR
User-defined
Time-delay
stochastic
model
Gene promoters,
mRNAs,
proteins
• Transcription (different transcri-
ption rate for each promoter state)
• Translation (1st order process)
• mRNA and protein decay (1st
order processes)
Table 1 Overview of existing methods of expression data simulation and their characteristics.
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sion of the SSA that is suited for the occurrence of delay in biochemical reactions.
This can account for the time required for the transcription of a gene as well as
the diffusion of molecules across cellular compartments. Additionally, spatial in-
homogeneities can be considered. For example, one might want to include in the
model the different cellular compartments, to account for the fact that in eukaryotic
cells the synthesis of mRNA occurs in the nucleus, while their translation happens
in the cytoplasm. This can be done in a deterministic framework by using partial
differential equations [24].
3.4 Assigning values for model parameters
When simulating in silico expression data, it is important to carefully choose the
values of the different parameters in the model to obtain more plausible data. The
initial abundance of each molecular species and the different reaction rates deter-
mine the resulting level of expression for each gene. It is crucial to use reasonable
values in the range of those estimated from experimental datasets. The same atten-
tion must be paid to the kinetic parameters that define the strength and amplitude
of regulation. This includes, for example, the Hill coefficients for a deterministic
model, or the binding and unbinding rates of the different TFs on the promoter for
a stochastic model. This choice is impeded by our limited knowledge about the pre-
cise kinetics of gene expression regulation [25]. However a number of experimental
results provide insights into the dynamics of the different molecular reactions, at
least for some model organisms [12, 116]. The global distribution of the lifetime of
transcripts and proteins, for example, is starting to be well-characterized across the
different domains of life. The order of magnitude of transcription and translation
rates are also available. In [82], Milo and Phillips gather relevant quantitative pieces
of information about different biological processes, from cell component typical
size estimates to the rates of transcription, translation or metabolic reactions. The
associated database, BioNumbers [81], allows to search the literature for quantita-
tive properties of biological systems. This is a valuable tool for modellers who seek
realistic values for model parameters. Additionally, during the model construction
it can be useful to conduct a sensitivity analysis to ensure that slight variations in
parameter values do not produce completely different and/or surrealistic system be-
haviours.
Despite the increasing availability of quantitative knowledge regarding gene
expression, to the best of our knowledge, none of the existing simulation tools
presently offer a rigorous justification of the values used in their model. The param-
eters are usually sampled from large distributions to allow a wide variety of pos-
sible dynamical behaviour (e.g. from quasi-linear to step-like regulatory functions)
[25, 27]. Alternatively, parameter values can be required as input from the user, as
it is the case in [94, 46, 110]. However the choice of values in the model often seem
arbitrary [78, 100, 103, 88]. An interesting approach has been proposed by Haynes
et al. [48]. In their model, the transcription, translation, transcript and protein decay
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rates are sampled from values experimentally measured for real genes in S. cere-
visiae. It should be noted however that this limits the validity of the simulations
to this organism. Moreover, this approach is only possible for well-characterized
model organisms for which abundant and reliable quantitative information is avail-
able.
In conclusion, it is important to anchor the mathematical RNA models in the
biological reality not only via the represented molecules and interactions, but also
through the quantitative information which is used to simulate the different reactions
involved in gene expression.
3.5 Experimental noise in in silico data
Even though the results of transcriptomics and other omics experiments provide an
estimation of transcripts or other molecules level, they do not exactly reflect their
precise in vivo abundance. Each step of the sample preparation process introduces to
some extent bias in the quantitative estimation of the molecular concentrations. Such
bias in turn impedes our ability to detect correlation between molecular profiles, or
introduces spurious correlations, and needs to be accounted for when developing
a reverse engineering approach. Consequently, when assessing the performance of
such methods, it is important to test their robustness against increasing level of noise
in the data.
Accordingly, several pipelines of data simulation include a step to add experi-
mental noise in the resulting simulated expression profiles to mimic errors and bias
introduced by the used measurement technology [78, 25, 48, 46, 103, 88]. This step
is particularly relevant for deterministic models, which produce data deprived of
both biological and experimental noise. On the opposite, stochastic models already
introduce some kind of variability in the dynamic profiles. The generation of in
silico experimental noise is often based on models linking the measured intensity
obtained with a particular technology (e.g. microarray or RNASeq [70]) to the true
underlying concentration [97, 55, 108]. Alternatively, a simple Gaussian noise can
be added to the simulated data to introduce variation in order to blur existing cor-
relations among molecular profiles [78, 46, 103, 88]. Mendes et al. proposed to use
a Gamma distribution for experimental noise, as microarray data are often found to
display a non-Gaussian noise and as the Gamma distribution is not centred around
its mean.
4 Concluding remarks
Biological systems are characterized by great complexity. From a systems perspec-
tive, regulatory networks are shaped according to specific properties that can be
described mathematically. From a mechanistic perspective, gene expression is reg-
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ulated at each step of the lifetime of the different gene products, that are transcripts
and proteins. Their synthesis, activity and decay is tightly controlled by a vast array
of factors ranging from proteins to noncoding transcripts and small molecules. Ad-
ditionally, these processes are affected by an inherent stochasticity which induces
variability in the molecular profiles. Statistical models provide a rich framework to
represent this complexity, and it is now possible to generate in silico graphs resem-
bling real networks, or to simulate biologically plausible noisy dynamic expression
data. A statistical model must be carefully designed to accurately reflect the un-
derlying processes, as for example determining the list of regulators of a molecule,
quantifying the effect of regulatory factors, or assigning a value to the different re-
action rates or other parameters.
In this chapter, we particularly focused on the use of GRN models for the sim-
ulation of expression data that can serve as benchmark for the testing of network
inference algorithms. Indeed it is important that these simulations provide realistic
data to allow researchers to draw meaningful conclusions about the performances of
reverse engineering methods. However, beyond the problem of simulating expres-
sion data, all the identified regulatory relationships allow the modeller to account
for a fine description of the underlying biological mechanisms, when such a level of
detail is required.
We know that all models presume to a greater or lesser extent a simplification
of the underlying biology. As we have shown in this chapter, most simulation mod-
els currently consider transcription regulation only, and exclude noncoding RNAs
and possibly even proteins. While these simplifications can be justified by our in-
sufficient knowledge about the processes at play or by computational limitations,
it results in inadequate models as they overlook the complexity of gene regulation.
We would however like to moderate this desire for increasingly detailed models that
could be more indicative of the underlying biological and technical influences in the
data. Indeed, they allow a great flexibility in the inferred interactions, but this can
become problematic and result in overfitting and in the detection of spurious regu-
lations. The need for a trade-off calls for the use of additional data for the reverse
engineering problem as well as advanced statistical tools accounting for the missing
information.
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